本实验旨在探究Mic60在小鼠卵母细胞体外成熟中的作用。选取4~6周龄的雌性C57BL/6J小鼠,注射孕马血清促性腺激素(PMSG)48 h后采集卵母细胞并随机分为对照组和Mic60抑制组(包括50、100、130、150μmol/L组,Miclxin组为130μmol/L)。卵母...本实验旨在探究Mic60在小鼠卵母细胞体外成熟中的作用。选取4~6周龄的雌性C57BL/6J小鼠,注射孕马血清促性腺激素(PMSG)48 h后采集卵母细胞并随机分为对照组和Mic60抑制组(包括50、100、130、150μmol/L组,Miclxin组为130μmol/L)。卵母细胞体外培养16 h后,通过免疫荧光染色检测纺锤体形态、ROS水平、线粒体分布和质量,利用qPCR检测抗氧化基因表达、线粒体呼吸链亚基的表达、整合应激反应相关基因的表达。结果表明:与对照组相比,130μmol/L Mic60抑制剂会降低卵母细胞体外成熟率(78.29%vs.21.08%,P<0.01),并显著阻碍纺锤体的组装;与对照组相比,Miclxin组卵母细胞中的ROS水平升高(P<0.05),且Sod1(0.83 vs. 0.22)和Sod2(0.84 vs. 0.27)基因表达降低(P<0.05),线粒体分布异常比例升高(0.16 vs. 0.57,P<0.05),线粒体膜电位水平降低(1.61 vs. 1.05,P<0.05),ATP产生降低(1.16 vs. 0.79,P<0.05);Miclxin组卵母细胞线粒体呼吸链复合体亚基Ndufv2和Sdha表达降低(P<0.05),Cyc1表达升高(P<0.05),卵母细胞mtDNA拷贝数降低(19 324 vs. 9 066,P<0.05);与对照组相比,Miclxin组卵母细胞Oma1、Dele1、Eif2ak1、eIF2α基因表达上调(P<0.05),触发了整合应激反应(Integrated Stress Response,ISR)并上调了ISR主要效应因子Atf4、Atf5和Chop的表达(P<0.05)。可见,抑制Mic60会通过损害线粒体功能并触发ISR影响卵母细胞体外成熟效果。展开更多
Mitochondrial dysfunction is a critical factor in the pathogenesis of Alzheimer’s disease(AD).The mitochondrial contact site and cristae organizing system(MICOS)plays a pivotal role in shaping the inner mitochondrial...Mitochondrial dysfunction is a critical factor in the pathogenesis of Alzheimer’s disease(AD).The mitochondrial contact site and cristae organizing system(MICOS)plays a pivotal role in shaping the inner mitochondrial membrane,forming cristae junctions and establishing interaction sites between the inner and outer mitochondrial membranes and thereby serving as a cornerstone of mitochondrial structure and function.In the past decade,MICOS abnormalities have been extensively linked to AD pathogenesis.In particular,dysregulated expression of MICOS subunits and mutations in MICOS-related genes have been identified in AD,often in association with hallmark pathological features such as amyloid-b plaque accumulation,neurofibrillary tangle formation,and neuronal apoptosis.Furthermore,MICOS subunits interact with several etiologically relevant proteins,significantly influencing AD progression.The intricate crosstalk between these proteins and MICOS subunits underscores the relevance of MICOS dysfunction in AD.Therapeutic strategies targeting MICOS subunits or their interacting proteins may offer novel approaches for AD treatment.In the present review,we introduce current understanding of MICOS structures and functions,highlight MICOS pathogenesis in AD,and summarize the available MICOS-targeting drugs potentially useful for AD.展开更多
目的线粒体的功能取决于线粒体的膜系统,而线粒体内膜的形态由近期发现的线粒体接触位点复合物(mitochondrial contact site and crista organizing system,MICOS)所调节,MICOS复合物的突变可改变嵴的形成,导致线粒体功能障碍。本研究...目的线粒体的功能取决于线粒体的膜系统,而线粒体内膜的形态由近期发现的线粒体接触位点复合物(mitochondrial contact site and crista organizing system,MICOS)所调节,MICOS复合物的突变可改变嵴的形成,导致线粒体功能障碍。本研究采用慢病毒shRNA靶向敲低MICOS复合物亚基蛋白-线粒体内膜蛋白Mic19及Mic60表达,并研究敲低Mic19和Mic60对肝癌细胞生物学作用的影响。方法根据NCBI中的序列设计、构建并包装敲低Mic19及Mic60的重组慢病毒,收集被病毒上清感染后经嘌呤霉素筛选得到的肝癌HepG2阳性细胞,并以空白组、空载pLKO.1慢病毒质粒组作为对照。采用蛋白印迹法检测Mic19及Mic60蛋白的表达,以筛选敲低效率最高的稳定细胞株。采用MTT法、划痕实验和Transwell实验检测细胞增殖、迁移和侵袭情况,观察敲低Mic19及Mic60蛋白表达对肝癌细胞生物学行为的影响。结果 Mic19敲低组中蛋白相对表达量shRNA Mic19-1(0.579±0.042)和shRNA Mic19-2(0.524±0.111)均低于空白组(1.065±0.105)或空载组(1.07±0.092),差异有统计学意义,均P<0.01。Mic60敲低组蛋白相对表达量shRNA Mic60-1(0.172±0.107)、shRNA Mic60-2(0.269±0.027)明显低于空白组(1.065±0.105)或空载组(1.07±0.092),差异有统计学意义,均P<0.01。生长曲线表明,Mic19敲低组至感染第36h时的吸光度(A)值低于对照组,均P<0.05;Mic60敲低组至感染第12h时的A值显著低于对照组,P<0.01。划痕实验表明,至第48hMic19敲低组细胞迁移距离为(286.8±38.97)μm,Mic60敲低组细胞迁移距离为(214.6±41.64)μm,与空白组(500.8±25.6)μm或空载组(487.3±31.37)μm相比差异均有统计学意义,均P<0.01。在不铺胶的Transwell迁移实验中,Mic19敲低组穿膜细胞数为(440.4±65.35)个/低倍视野,Mic60敲低组穿膜细胞数为(235.2±21.3)个/低倍视野,均少于空白组(574.8±36.4)或空载组(574±53.95)个/低倍视野,均P<0.01。在铺胶的侵袭实验中,Mic19敲低组穿膜细胞数为(172.4±15.5)个/低倍视野,Mic60敲低组穿膜细胞数为(118.2±25.53)个/低倍视野,均少于对照组空白组(238.6±22.85)或空载组(227.8±22.27)个/低倍视野,差异有统计学意义,均P<0.01。结论重组慢病毒shRNA Mic19-2、shRNA Mic60-1可分别有效敲低HepG2细胞Mic19、Mic60的表达。慢病毒shRNA靶向敲低Mic19及Mic60表达可抑制肝癌HepG2细胞的增殖、迁移和侵袭能力,并为后续进一步研究线粒体内膜蛋白(Mic19、Mic60)对肝癌细胞发生发展的影响提供依据。展开更多
文摘本实验旨在探究Mic60在小鼠卵母细胞体外成熟中的作用。选取4~6周龄的雌性C57BL/6J小鼠,注射孕马血清促性腺激素(PMSG)48 h后采集卵母细胞并随机分为对照组和Mic60抑制组(包括50、100、130、150μmol/L组,Miclxin组为130μmol/L)。卵母细胞体外培养16 h后,通过免疫荧光染色检测纺锤体形态、ROS水平、线粒体分布和质量,利用qPCR检测抗氧化基因表达、线粒体呼吸链亚基的表达、整合应激反应相关基因的表达。结果表明:与对照组相比,130μmol/L Mic60抑制剂会降低卵母细胞体外成熟率(78.29%vs.21.08%,P<0.01),并显著阻碍纺锤体的组装;与对照组相比,Miclxin组卵母细胞中的ROS水平升高(P<0.05),且Sod1(0.83 vs. 0.22)和Sod2(0.84 vs. 0.27)基因表达降低(P<0.05),线粒体分布异常比例升高(0.16 vs. 0.57,P<0.05),线粒体膜电位水平降低(1.61 vs. 1.05,P<0.05),ATP产生降低(1.16 vs. 0.79,P<0.05);Miclxin组卵母细胞线粒体呼吸链复合体亚基Ndufv2和Sdha表达降低(P<0.05),Cyc1表达升高(P<0.05),卵母细胞mtDNA拷贝数降低(19 324 vs. 9 066,P<0.05);与对照组相比,Miclxin组卵母细胞Oma1、Dele1、Eif2ak1、eIF2α基因表达上调(P<0.05),触发了整合应激反应(Integrated Stress Response,ISR)并上调了ISR主要效应因子Atf4、Atf5和Chop的表达(P<0.05)。可见,抑制Mic60会通过损害线粒体功能并触发ISR影响卵母细胞体外成熟效果。
基金funded by the National Natural Science Foundation of China(No.81500858 to Xinwen Zhang,No.81700977 to Xu Yan)Natural Science Foundation of Liaoning Province(China)(No.2022-MS-231 to Xinwen Zhang)+1 种基金the Science and Technology Planning Project of Shenyang(China)(No.22-321-33-26 to Dehao Shang)Grants-in-Aid for Scientific Research(Japan)(No.22K09927 to Zhou Wu).
文摘Mitochondrial dysfunction is a critical factor in the pathogenesis of Alzheimer’s disease(AD).The mitochondrial contact site and cristae organizing system(MICOS)plays a pivotal role in shaping the inner mitochondrial membrane,forming cristae junctions and establishing interaction sites between the inner and outer mitochondrial membranes and thereby serving as a cornerstone of mitochondrial structure and function.In the past decade,MICOS abnormalities have been extensively linked to AD pathogenesis.In particular,dysregulated expression of MICOS subunits and mutations in MICOS-related genes have been identified in AD,often in association with hallmark pathological features such as amyloid-b plaque accumulation,neurofibrillary tangle formation,and neuronal apoptosis.Furthermore,MICOS subunits interact with several etiologically relevant proteins,significantly influencing AD progression.The intricate crosstalk between these proteins and MICOS subunits underscores the relevance of MICOS dysfunction in AD.Therapeutic strategies targeting MICOS subunits or their interacting proteins may offer novel approaches for AD treatment.In the present review,we introduce current understanding of MICOS structures and functions,highlight MICOS pathogenesis in AD,and summarize the available MICOS-targeting drugs potentially useful for AD.
